| Circumventricular Organs | |
|---|---|
| Type | Neuroendocrine interface |
| Location | Third and fourth ventricles |
| Key Features | Fenestrated capillaries, no blood-brain barrier |
| Brain Regions | Median eminence, OVLT, SFO, AP, PI, SC |
| Disease Relevance | Alzheimer's Disease, Parkinson's Disease, Neuroinflammation |
Circumventricular Organs is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Circumventricular organs (CVOs) are a collection of specialized neuroendocrine structures located along the walls of the third and fourth ventricles of the brain. Unlike most brain regions, CVOs possess fenestrated capillaries that lack a normal blood-brain barrier (BBB), allowing bidirectional communication between the central nervous system and peripheral blood circulation [1]. This unique feature makes CVOs critical interfaces for neuroendocrine regulation, autonomic control, and immune-brain communication.
The CVOs play essential roles in maintaining homeostasis by sensing circulating molecules (hormones, cytokines, toxins) that cannot normally cross the BBB and integrating this information into central neural circuits [2]. These structures have become increasingly recognized as important players in neurodegenerative diseases, where BBB dysfunction and neuroinflammation are hallmarks of disease progression.
The circumventricular organs are classified into two categories based on their function: secretory CVOs (which release substances into the blood) and sensory CVOs (which sample blood-borne molecules).
The median eminence (ME) is located in the floor of the third ventricle and forms part of the hypothalamic-pituitary axis. It serves as the primary portal system through which hypothalamic releasing and inhibiting hormones access the anterior pituitary [3].
The OVLT is located in the anterior wall of the third ventricle and functions as the primary osmoreceptor site in the brain [4].
The subfornical organ (SFO) is the most studied CVO and is crucial for cardiovascular and fluid balance [5].
The area postrema (AP) is the primary chemoreceptor trigger zone and is critical for emesis (vomiting) [6].
The pineal gland (also called epiphysis) is a secretory CVO that produces melatonin and regulates circadian rhythms [7].
The subcommissural organ (SCO) is located beneath the posterior commissure and secretes glycoproteins into the cerebrospinal fluid [8].
The sensory CVOs lack secretory functions but contain specialized neurons that detect circulating molecules:
The defining feature of CVOs is their fenestrated capillaries, which have:
Despite lacking a classical BBB, CVOs express various transporters:
CVOs integrate information through extensive neural connections:
CVOs serve as critical interfaces between the peripheral immune system and the central nervous system [9]:
In neurodegenerative diseases, the distinction between CVOs and BBB-protected brain regions becomes blurred:
CVOs are increasingly recognized in AD pathophysiology:
CVOs play several roles in PD:
CVOs offer unique opportunities for drug delivery:
The study of Circumventricular Organs has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Duvernoy, H.M. (1999). The circumventricular organs: an atlas of their comparative anatomy and functional aspects. Progress in Brain Research. 1999. ↩︎
Gross, P.M. et al. (1990). Circumventricular organs: new views on their function. News in Physiological Sciences. 1990. ↩︎
Rodriguez, E.M. et al. (2010). The median eminence as a neuroendocrine organ. Progress in Brain Research. 2010. ↩︎
McKinley, M.J. et al. (2003). The OVLT: osmoreceptor site for thirst. Progress in Brain Research. 2003. ↩︎
Ferguson, A.V. & Bains, J.S. (1996). Electrophysiology of the circumventricular organs. Frontiers in Neuroendocrinology. 1996. ↩︎
Miller, A.D. & Leslie, R.A. (1994). The area postrema and vomiting. Frontiers in Neuroendocrinology. 1994. ↩︎
Arendt, J. & Skene, D.J. (2005). Melatonin as a chronobiotic. Sleep Medicine Reviews. 2005. ↩︎
Rodriguez, E.M. et al. (1992). The subcommissural organ: a neuroendocrine gland. Microscopy Research and Technique. 1992. ↩︎
Banks, W.A. (2015). The blood-brain barrier in neuroimmunology. Journal of Neuroimmunology. 2015. ↩︎
Zlokovic, B.V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease. Journal of Clinical Investigation. 2011. ↩︎
Zhou, J.N. et al. (2003). Alterations in melatonin in Alzheimer's disease. Journal of Pineal Research. 2003. ↩︎
Dinu, A.R. et al. (2020). Area postrema and Parkinson's disease. Movement Disorders. 2020. ↩︎
Braak, H. et al. (2003). Staging of brain pathology in sporadic Parkinson's disease. Neurobiology of Aging. 2003. ↩︎
Lin, L. et al. (2013). Melatonin in Alzheimer's disease. Current Neuropharmacology. 2013. ↩︎